Non-competitive NMDA receptor antagonist (open-channel blocker) + opioid + monoamine reuptake effects. Dissociative anesthetic preserving airway reflexes. Sub-anesthetic IV / intranasal (esketamine) for treatment-resistant depression. Schedule III; recreational misuse signal.